Henrik Winther
Henrik was an Associate Professor in Anatomy, Physiology, and Cell Biology at the University of Copenhagen prior to taking employment at the diagnostics company Dako, which was later acquired by Agilent. Henrik held several executive management positions at Dako. He was the R&D Director prior to taking over as Business Area Manager for Companion Diagnostics. Under his management, the business area experienced tenfold growth in both revenue and the number of employees. At Agilent, Henrik was appointed Vice President and General Manager of the Companion Diagnostics Division.
Prior to his employment at Biovica, Henrik worked as SVP of Business Development at the Swedish diagnostics company, Immunovia.
Holdings: 25 161 class B shares.
Stock options: 13 000 SSP 24/27: 1 RSU and 39 000 SSP 24/27:1 PRSU.
>4,500
Numbers of patients in studies
28
Publications
22
Pharma Projects